Recent trends in cutaneous melanoma incidence among whites in the United States.

BACKGROUND It is not yet clear whether increasing melanoma incidence is real or whether recent incidence trends mainly reflect improved diagnosis. To address this question, we examined the most recent melanoma incidence patterns among the white population stratified by sex, age, tumor stage, and tumor thickness by use of data from the Surveillance, Epidemiology, and End Results Program. METHODS We examined log-transformed age-specific rates for melanoma by 5-year age groups and time periods by year of diagnosis and birth cohort. Melanoma trends were further examined among broader age groups (<40 years, 40-59 years, and > or =60 years) by tumor stage and tumor thickness. Rates were age-adjusted to the 1970 U.S. standard population, and trends were tested by use of a two-sided Student's t test. RESULTS Melanoma incidence increased in females born since the 1960s. From 1974-1975 through 1988-1989, upward trends for the incidence of localized tumors and downward trends for the incidence of distant-stage tumors occurred in the age group under 40 years. In the more recent time period, 1990-1991 through 1996-1997, age specific rates among females compared with males generally remained stable or declined more for distant-stage tumors and increased less for local-stage tumors. Thin tumors (<1 mm) increased statistically significantly in all age groups (P<.05 for all), except in men under age 40 years. In contrast, rates for thick tumors (> or =4 mm) increased statistically significantly (P =.0003) only in males aged 60 years and older. CONCLUSION Melanoma incidence may well continue to rise in the United States, at least until the majority of the current population in the middle-age groups becomes the oldest population. The recent trends may reflect increased sunlight exposure.

[1]  J. Nectoux,et al.  Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely , 1991, International journal of cancer.

[2]  A. Halpern,et al.  A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma , 1996, Annals of Internal Medicine.

[3]  B. Armstrong,et al.  Cutaneous melanoma. , 1994, Cancer surveys.

[4]  G. W. Snedecor STATISTICAL METHODS , 1967 .

[5]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[6]  Daniel S. Miller,et al.  The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.

[7]  D. Skegg,et al.  Trends in malignant melanoma of skin in New Zealand , 1983, International journal of cancer.

[8]  D. Rigel,et al.  Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. , 1996, Journal of the American Academy of Dermatology.

[9]  B. Gilchrest,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[10]  L. Dennis,et al.  Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. , 1999, Archives of dermatology.

[11]  T. Fears,et al.  Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. , 1977, American journal of epidemiology.

[12]  A. Jemal,et al.  Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. , 2000, Journal of the National Cancer Institute.

[13]  L. Merlino,et al.  The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. , 1997, Journal of the American Academy of Dermatology.

[14]  T. Fears,et al.  Graphical presentation of trends in rates. , 1995, American journal of epidemiology.

[15]  S. Walter,et al.  Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. , 1999, International journal of epidemiology.

[16]  B. Schneider MANUAL of the international statistical classification of diseases, injuries, and causes of death. Addendum 1. Supplementary interpretations and instructions for coding causes of death. , 1953, Bulletin of the World Health Organization. Supplement.

[17]  R. Clapp,et al.  Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figures. , 1991, Journal of the American Academy of Dermatology.

[18]  U. Ringborg Review: Cutaneous Malignant Melanoma , 1996 .

[19]  R. Tarone,et al.  Evaluation of birth cohort patterns in population disease rates. , 1996, American journal of epidemiology.

[20]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure , 1988, International journal of cancer.

[21]  Pressure support ventilation. , 1996, Archives of internal medicine.

[22]  J. Scotto,et al.  Indications of future decreasing trends in skin‐melanoma mortality among whites in the United States , 1991, International journal of cancer.

[23]  R. Philipp,et al.  Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions? , 1988, Journal of epidemiology and community health.

[24]  D. Rigel,et al.  Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. , 1997, Journal of the American Academy of Dermatology.

[25]  R. Swerlick,et al.  The melanoma epidemic: more apparent than real? , 1997, Mayo Clinic proceedings.

[26]  R N Hoover,et al.  The emerging epidemic of melanoma and squamous cell skin cancer. , 1989, JAMA.

[27]  A. Streetly,et al.  Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. , 1995, International journal of epidemiology.

[28]  D. Miller,et al.  Update on the incidence and mortality from melanoma in the United States. , 1999, Journal of the American Academy of Dermatology.